Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record now lists NIH grant/contract years 2018 and 2023 in the funding information, and the revision label was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:25:24.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now displays an error screen instead of the study record. This prevents access to the study details and related information on NCT03815058.
    Difference
    17%
    Check dated 2026-08-09T12:00:30.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, indicating a backend update to the ClinicalTrials.gov page. This update appears to be a software version change rather than a modification to study details.
    Difference
    0.0%
    Check dated 2026-07-25T23:59:06.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A new revision tag v3.6.3 was added and the previous v3.6.2 tag was removed from the page, updating the revision history.
    Difference
    0.0%
    Check dated 2026-07-04T13:03:42.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.0 to v3.6.2, indicating a minor behind-the-scenes update to the page version.
    Difference
    0.0%
    Check dated 2026-06-27T06:41:30.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    The page adds a line indicating recruitment is closed ('No longer looking for participants') and introduces new or reorganized sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', plus a Revision: v3.6.0 notice.
    Difference
    0.3%
    Check dated 2026-06-13T00:21:01.000Z thumbnail image

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.